中、日、韩三国中医药SCI论文计量分析

以SCIE平台为数据来源,从发文量、被引情况、语种、期刊、学科、机构、国际合作等方面,对SCIE平台收录的1996—2015年中国、日本、韩国发表的中医药领域论文进行计量分析。我国SCI论文的发文总量、被引总量大幅领先日本、韩国,篇均被引次数近年来与日本、韩国持平。超过97%的论文以英语发表。发文量Top 10期刊影响因子主要分布在1~3分左右,以替代医学、药理/药学、化学领域期刊为主。药理学/药剂学、化学、生物化学/分子生物学是中医药SCI论文发文量最大的领域,其发文量、被引次数高于替代医学。中国科学院系统、综合性大学是中医药科研的重要力量,且论文篇均被引次数普遍高于中医药院校。中国的国际合作率低于日本、韩国。国际合作论文的被引次数高于非国际合作论文的被引次数。我国中医药科研水平与日本、韩国接近,但在规模上更具优势。中药学是中医药研究领域的优势学科。与中国科学院系统、综合性大学相比,我国中医药院校的科研影响力需要进一步提高。我国中医药科研国际合作率偏低,需要加强中医药国际科研合作实力。

A bibliometric analysis of SCI publications on traditional Chinese medicine by researchers from China, Japan, and Korea

A bibliometric analysis was performed on Science Citation Index Expanded (SCIE) from the aspects of the amounts of publications and citations, language, journals, subject categories, organizations, and international collaborations. The amounts of total publications and citations of China have largely exceeded Japan and Korea, and the amounts of citations per article are close to each other. More than 97% of papers are written in English. The impact factors of Top 10 journals sorted by number of publications are from 1 to 3. The most appear categories are integrative & complementary medicine, pharmacology & pharmacy, and chemistry. Pharmacology pharmacy, chemistry, and biochemistry molecular biology are the Top 3 subjects that sorted by the number of publications of traditional Chinese medicine (TCM). Both the amount of publications and citations of the Top 3 subjects are bigger than the subject of integrative complementary medicine. Chinese academy of science and comprehensive universities, whose amount of publications and citations per article are generally higher than universities of TCM, are important participants in the research of TCM. The rate of international collaboration of China is lower than those in Japan and Korea. The number of citations per article of international collaboration publications is higher than domestic publications. The research ability of scientists from China, Japan, and Korea is close to each other in the subject of TCM. But China has advantages in the amount of publications and citations. For TCM, the development of pharmacology pharmacy is ahead of therapeutic method. Compared with Chinese academy of science and comprehensive universities, TCM universities need to improve their scientific performance. Because the international scientific collaboration is insufficient, scientific international collaborations need to be strengthened by researchers from China.